By Application
Hot products 
-
Mouse Anti-ABIN2 Recombinant Antibody (V2-179106) (CBMAB-A0349-YC)
-
Mouse Anti-FAS2 Monoclonal Antibody (1D4) (CBMAB-0071-CN)
-
Mouse Anti-AAV-5 Recombinant Antibody (V2-503416) (CBMAB-V208-1402-FY)
-
Mouse Anti-CASQ1 Recombinant Antibody (CBFYC-0863) (CBMAB-C0918-FY)
-
Mouse Anti-BrdU Recombinant Antibody (IIB5) (CBMAB-1038CQ)
-
Mouse Anti-AMACR Recombinant Antibody (CB34A) (CBMAB-CA034LY)
-
Rabbit Anti-ATF4 Recombinant Antibody (D4B8) (CBMAB-A3872-YC)
-
Human Anti-SARS-CoV-2 Spike Recombinant Antibody (CR3022) (CBMAB-CR014LY)
-
Mouse Anti-DISP2 Monoclonal Antibody (F66A4B1) (CBMAB-1112CQ)
-
Rabbit Anti-ALDOA Recombinant Antibody (D73H4) (CBMAB-A2314-YC)
-
Mouse Anti-CARD11 Recombinant Antibody (CBFYC-0811) (CBMAB-C0866-FY)
-
Mouse Anti-ARIH1 Recombinant Antibody (C-7) (CBMAB-A3563-YC)
-
Mouse Anti-GDF5 Recombinant Antibody (1F4) (CBMAB-G2740-LY)
-
Mouse Anti-AMIGO2 Recombinant Antibody (CBYY-C0756) (CBMAB-C2192-YY)
-
Mouse Anti-HTLV-1 gp46 Recombinant Antibody (CBMW-H1006) (CBMAB-V208-1154-FY)
-
Mouse Anti-CD164 Recombinant Antibody (CBFYC-0077) (CBMAB-C0086-FY)
-
Mouse Anti-COL12A1 Recombinant Antibody (CBYY-C3117) (CBMAB-C4560-YY)
-
Mouse Anti-C4B Recombinant Antibody (CBYY-C2996) (CBMAB-C4439-YY)
-
Mouse Anti-GIPC2 Recombinant Antibody (10) (CBMAB-G0476-LY)
-
Mouse Anti-GluRIIA Monoclonal Antibody (8B4D2) (CBMAB-0305-CN)
Lung Cancer
Fig.1 Lung cancer
Lung cancer, also named as lung carcinoma, is characterized by uncontrolled cell growth in the tissues of lung. The two major types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC), which are malignant lung tumor. The most obvious symptoms are coughing (coughing up blood included), shortness of breath, chest pains and weight loss. The vast majority (85%) of lung cancer are on account of long-term tobacco smoking. Around 10–15% of cases occur in those who have never smoked before. These cases are often caused by a combination of genetic factors and exposure to harmful gas, such as: radon gas, second-hand smoke, asbestos or other forms of air pollution. Mutations in the K-ras proto-oncogene account for 10–30% of lung adenocarcinomas. Around 4% of non-small-cell lung carcinomas are considered to involve an EML4-ALK tyrosine kinase fusion gene. Tumor markers, such as CEA and CYFRA 21-1 are of great diagnostic value in primary lung cancer.
Loading...
Compare
